Cancer exosomes as mediators of drug resistance

19Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In the last decades, several studies demonstrated that the tumor microenvironment is a critical determinant not only of tumor progression and metastasis, but also of resistance to therapy. Exosomes are small membrane vesicles of endocytic origin, which contain mRNAs, DNA fragments, and proteins, and are released by many different cell types, including cancer cells. Mounting evidence has shown that cancer-derived exosomes contribute to the recruitment and reprogramming of constituents associated with the tumor microenvironment. Understanding how exosomes and the tumor microenvironment impact drug resistance will allow novel and better strategies to overcome drug resistance and treat cancer. Here, we describe a technique for exosome purification from cell culture, and fresh and frozen plasma, and further analysis by electron microscopy, NanoSight microscope, and Western blot.

Cite

CITATION STYLE

APA

André, M. D. R., Pedro, A., & Lyden, D. (2016). Cancer exosomes as mediators of drug resistance. In Methods in Molecular Biology (Vol. 1395, pp. 229–239). Humana Press Inc. https://doi.org/10.1007/978-1-4939-3347-1_13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free